网站综合信息 www.amarincorp.com
    • 标题:
    • Redirecting... 
    • 关键字:
    • Amarin cardiovascular Omega 3 hypertriglyceridemia dyslipidemia l 
    • 描述:
    • Amarin is a clinical stage biopharmaceutical company with a lead program in Phase 3 for hypertriglyc 
    • 域名信息
    • 域名年龄:23年6个月2天  注册日期:2002年01月06日  到期时间:2017年01月06日
      注册商:WILD WEST DOMAINS, LLC 
    • 服务器空间
    • IP:50.62.160.216 同IP网站6个 详情
      地址:美国 亚利桑那州斯科茨代尔市Go Daddy集团公司
    • 备案信息
    • 备案号: 
    网站收录SEO数据
    • 搜索引擎
    • 收录量
    • 反向链接
    • 其他
    • Google
    • 0  
    • 0  
    • pr:5  
    • 雅虎
    • 0  
    •  
    •  
    • 搜搜
    • 0  
    •  
    •  
    • 搜狗
    • 0  
    •  
    • 评级:0/10  
    • 360搜索
    • 0  
    •  
    •  
    域名流量Alexa排名
    •  
    • 一周平均
    • 一个月平均
    • 三个月平均
    • Alexa全球排名
    • 3,000,851  
    • 平均日IP
    • 日总PV
    • 人均PV(PV/IP比例)
    • 反向链接
    • 133 
    • dmoz目录收录
    • Business/Biotechnology_and_Pharmaceuticals/Pharmaceuticals/Manufacturing  

    • 流量走势图
    域名注册Whois信息

    amarincorp.com

    域名年龄: 23年6个月2天
    注册时间: 2002-01-06
    到期时间: 2017-01-06
    注 册 商: WILD WEST DOMAINS, LLC

    获取时间: 2016年02月29日 01:16:21
    Domain Name: AMARINCORP.COM
    Registrar: WILD WEST DOMAINS, LLC
    Sponsoring Registrar IANA ID: 440
    Whois Server: whois.wildwestdomains.com
    Referral URL: http://www.wildwestdomains.com
    Name Server: NS01.DOMAINCONTROL.COM
    Name Server: NS02.DOMAINCONTROL.COM
    Status: clientDeleteProhibited https://www.icann.org/epp#clientDeleteProhibited
    Status: clientRenewProhibited https://www.icann.org/epp#clientRenewProhibited
    Status: clientTransferProhibited https://www.icann.org/epp#clientTransferProhibited
    Status: clientUpdateProhibited https://www.icann.org/epp#clientUpdateProhibited
    Updated Date: 2015-12-11
    Creation Date: 2002-01-06
    Expiration Date: 2017-01-06

    >>> Last update of whois database: Sun, 2016-Feb-28 17:20:08 GMT <<<

    For more information on Whois status codes, please visit https://icann.org/epp

    Domain Name: AMARINCORP.COM
    Registrar URL: http://www.wildwestdomains.com
    Registrant Name: Amarin Pharma
    Registrant Organization: Amarin Pharma Inc.
    Name Server: NS01.DOMAINCONTROL.COM
    Name Server: NS02.DOMAINCONTROL.COM
    DNSSEC: unsigned

    For complete domain details go to:
    http://who.securepaynet.net/whoischeck.aspx?domain=AMARINCORP.COM&prog_id=innotech

    The data contained in this Registrar's Whois database,
    while believed by the registrar to be reliable, is provided "as is"
    with no guarantee or warranties regarding its accuracy. This information
    is provided for the sole purpose of assisting you in obtaining
    information about domain name registration records. Any use of
    this data for any other purpose is expressly forbidden without
    the prior written permission of this registrar. By submitting an
    inquiry, you agree to these terms of usage and limitations of warranty.
    In particular, you agree not to use this data to allow, enable, or
    otherwise make possible, dissemination or collection of this data, in
    part or in its entirety, for any purpose, such as the transmission of
    unsolicited advertising and solicitations of any kind, including spam.
    You further agree not to use this data to enable high volume, automated
    or robotic electronic processes designed to collect or compile this data
    for any purpose, including mining this data for your own personal or
    commercial purposes.

    Please note: the owner of the domain name is specified in the "registrant" section.
    In most cases, the Registrar is not the owner of domain names listed in this database.
    其他后缀域名
    • 顶级域名
    • 相关信息
    网站首页快照(纯文字版)
    抓取时间:2016年02月29日 01:16:18
    网址:http://www.amarincorp.com/
    标题:Redirecting...
    关键字:Amarin, cardiovascular, Omega-3, hypertriglyceridemia, dyslipidemia, lipid science, research, development, drugs, centra
    描述:Amarin is a clinical stage biopharmaceutical company with a lead program in Phase 3 for hypertriglyceridemia.
    主体:
    Home | Site Map | Careers | Contact Us 
    | Printer Version
    Home | Site Map | Careers | Contact Us 
    | Graphic Version
    ABOUT US
    Company Profile
    Executive Team
    Board of Directors
    Contact Us
    THERAPEUTIC FOCUS
    Cardiovascular
    RESEARCH & DEVELOPMENT
    Development Program
    PRODUCT
    Vascepa®
    Authorized Distributor List
    PUBLICATIONS
    Publications
    PARTNERING
    Partnering
    INVESTOR RELATIONS
    Overview
    CAREERS
    Career Opportunities
    Recent Press Releases
    31-Mar-2014
    Amarin and Kowa Pharmaceuticals America, Inc. Announce U.S. Co-Promotion Agreement for Vascepa® (icosapent ethyl) Capsules
    27-Feb-2014
    Amarin Reports Fourth Quarter and Year-End 2013 Financial Results and Provides Update on Operations
    Advancing The Science Of Lipid Therapy
    Amarin Corporation plc is a biopharmaceutical company focused on the commercialization 
    and development of therapeutics to improve cardiovascular health. Amarin's product 
    development program leverages its extensive experience in lipid science and the 
    potential therapeutic benefits of polyunsaturated fatty acids. Vascepa® (icosapent 
    ethyl) is Amarin's first FDA approved product and is available in the United States 
    by prescription. For more information about Vascepa visit  www.vascepa.com.
    Approved Product
    See full prescribing information for Vascepa link to label
    Link to Vascepa Approval press release
    NASDAQ (AMRN)
    Downloads
    Link to Investor Relations for corporate presentation and other downloads
    Copyright ©
    Amarin Corp. All rights reserved.
    Disclaimer | Privacy Policy

    © 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询

    2025-07-01 02:28, Process in 0.0056 second.